SCHEMBL4677585

SCHEMBL4677585

O=C(O)C(O)=CC(=O)c1cc(Sc2ccccc2)n[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
TP53 P04637 1/20 0.35
PIN1 Q13526 1/20 0.32
CHEK1 O14757 1/20 0.32
RET P07949 1/20 0.32
PDGFRB P09619 1/20 0.32
PIM1 P11309 1/20 0.32
PDGFRA P16234 1/20 0.32
GSK3B P49841 1/20 0.32
RPS6KA3 P51812 1/20 0.32
LIMK1 P53667 1/20 0.32
CDK5 Q00535 1/20 0.32
TYRO3 Q06418 1/20 0.32
MAPK14 Q16539 1/20 0.32
LRRK2 Q5S007 1/20 0.32
AURKB Q96GD4 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
DYRK1B Q9Y463 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4671100 0.75 ALDH1A1 (0.33) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL4671103 0.75 ALDH1A1 (0.33) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL4673256 0.74 MCL1 (0.41) NCOA1NCOA3GAAALDH1A1HPGD
SCHEMBL4673259 0.74 MCL1 (0.41) NCOA1NCOA3GAAALDH1A1HPGD
SCHEMBL4675551 0.72 HCAR2 (0.41) TP53CHEK1RETPDGFRBPIM1
SCHEMBL4675935 0.71 AKR1B1 (0.46) TP53GAAALDH1A1MAPT
SCHEMBL4676420 0.70 ALDH1A1 (0.35) GAAALDH1A1HPGDMEN1HTT
SCHEMBL4674238 0.70 NCOA1 (0.36) NCOA1NCOA3ALDH1A1HPGDMEN1
SCHEMBL4674236 0.70 NCOA1 (0.36) NCOA1NCOA3ALDH1A1HPGDMEN1
SCHEMBL4676418 0.70 ALDH1A1 (0.35) GAAALDH1A1HPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 NOTUM 1685/4885NCOA1 244/4885NCOA3 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.